Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.
Sci Rep. 2018 Nov 19;8(1):16970. doi: 10.1038/s41598-018-34978-4.
Sci Rep. 2018.
PMID: 30451888
Free PMC article.
Clinical Trial.